M3L.F Modern Healthcare Technology Holdings Limited
- Market cap
- EUR 6.78M
- P/E
- -
- P/B
- 0.30x
- ROE
- -0.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Mar 2026.
Is M3L.F undervalued?
Graham numberThe Graham number of Modern Healthcare Technology Holdings Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Modern Healthcare Technology Holdings Limited fundamental analysis
No fundamental analysis for Modern Healthcare Technology Holdings Limited yet.
Modern Healthcare Technology Holdings Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Modern Healthcare Technology Holdings Limited
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, Singapore, and Australia. The company operates in two segments, Beauty and wellness services, and Skincare and wellness products. It offers skincare, slimming, massage, spa, hair care, manicure, pedicure, hair removal, make-up, joint care, intimate care, body check, genetic test, and other services. The company also sells skincare and wellness pro…
Full company profileModern Healthcare Technology Holdings Limited financial statements
Modern Healthcare Technology Holdings Limited annual financial statements (HKD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 693M | 599M | 576M | 523M | 431M | 356M | 406M | 455M | 453M | 443M |
| Gross Profit | 671M | 576M | 552M | 504M | 418M | 342M | 395M | 167M | 153M | 167M |
| Operating Income | 71.4M | -730K | 23.4M | 5.73M | 144M | -56.6M | -1.08M | 9.46M | 13.8M | 33.2M |
| EBITDA | - | -10.5M | 38.7M | 47.2M | 241M | 26.4M | 70.7M | 73.0M | 77.1M | 78.1M |
| Net Income | 33.3M | -22.9M | -13.3M | -31.6M | 126M | -68.8M | -20.6M | -9.57M | -5.07M | -1.76M |
| EPS | 0.04 | -0.03 | -0.01 | -0.03 | 0.14 | -0.08 | -0.02 | -0.01 | -0.01 | 0.00 |
| Balance Sheet | ||||||||||
| Total Assets | 656M | 611M | 579M | 620M | 669M | 571M | 561M | 611M | 564M | 521M |
| Total Liabilities | 530M | 522M | 393M | 468M | 376M | 348M | 357M | 417M | 373M | 328M |
| Shareholders' Equity | 123M | 85.8M | 181M | 147M | 289M | 220M | 200M | 189M | 186M | 187M |
| Cash & Short-term Investments | 245M | 182M | 183M | 175M | 229M | 122M | 172M | 188M | 222M | 247M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -36.6M | -26.0M | 33.5M | 63.9M | 124M | 51.3M | 140M | 78.7M | 151M | 80.1M |
| Capital Expenditure | 1.29M | 21.3M | 32.6M | 20.0M | 2.23M | 80.9M | 14.3M | 14.6M | 16.1M | 3.07M |
| Free Cash Flow | - | -47.4M | 937K | 43.9M | 122M | -29.5M | 126M | 64.1M | 135M | 77.1M |
| Ratios | ||||||||||
| ROE | 27.1% | -26.6% | -7.3% | -21.5% | 43.4% | -31.3% | -10.3% | -5.1% | -2.7% | -0.9% |
| ROA | 5.1% | -3.7% | -2.3% | -5.1% | 18.8% | -12.1% | -3.7% | -1.6% | -0.9% | -0.3% |
| Net Profit Margin | 4.8% | -3.8% | -2.3% | -6.0% | 29.1% | -19.4% | -5.1% | -2.1% | -1.1% | -0.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Modern Healthcare Technology Holdings Limited dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Aug 31, 2017
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | EUR 11.3M | 0.01 | - |
| 2017 | EUR 14.0M | 0.02 | 42.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Modern Healthcare Technology Holdings Limited
- Insiders 74.99%
- Institutions 0.00%
- Public & others 25.01%
- Shares outstanding 904M
- Free float 226M
Modern Healthcare Technology Holdings Limited company profile
- Company name
- Modern Healthcare Technology Holdings Limited
- Ticker
- M3L.F
- ISIN
- KYG618101003
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Cyclical
- Industry
- Diversified Consumer Services
- Employees
- 783
- Fiscal year end
- March
- Address
- Sino Industrial Plaza, Kowloon Bay, Hong Kong
- Phone
- 852 2866 2377
- Website
- modernhealthcaretech.com
About Modern Healthcare Technology Holdings Limited
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, Singapore, and Australia. The company operates in two segments, Beauty and wellness services, and Skincare and wellness products. It offers skincare, slimming, massage, spa, hair care, manicure, pedicure, hair removal, make-up, joint care, intimate care, body check, genetic test, and other services. The company also sells skincare and wellness products under the Y.U.E, Advanced Natural, be, Care Plus, Cellnoc, Malu Wilz, Dr Plus, Castille, Eclat du teint, p.e.n, FERRECARE, Byotea, Mu-lan Spa, Natural Care, and Veribel brands names. The company was formerly known as Modern Beauty Salon Holdings Limited and changed its name to Modern Healthcare Technology Holdings Limited. The company was incorporated in 2005 and is headquartered in Kowloon Bay, Hong Kong.
Modern Healthcare Technology Holdings Limited management
5- Dr. Yue TsangFounder, Chairperson & CEO · born 1961
- Mr. Kai Wing YipCTO & Executive Director · born 1974
- Ms. See Man YeungFinancial Controller & Executive Director · born 1974
- Mr. Chi Ming ChengCFO & Company Secretary · born 1966
- Dr. Soo Ghee LeeChief Administrative Officer · born 1975